{"url_path":"/sec/achv/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/949858/0001193125-26-344571-index.html","accession_number":"0001193125-26-344571","cik":"0000949858","ticker":"ACHV","issuer_name":"ACHIEVE LIFE SCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/949858/0001193125-26-344571-index.html","primary_entity_key":"0000949858","primary_entity_name":"ACHIEVE LIFE SCIENCES, INC."},"word_count":161,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.\n\nDescription\n\n99.1\n\n \n\n104\n\n[Press release of Achieve Life Sciences, Inc. dated August 11, 2026](achv-ex99_1.htm)\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n________________________\n\nThe information in Item 2.02 of this Form 8-K and Exhibit 99.1 attached hereto is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.\n\n________________________\n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\n \n\nACHIEVE LIFE SCIENCES, INC.\n\n \n\nDate: August 11, 2026\n\n \n\n/s/ MARK OKI\n\n \n\nMark Oki\n\nChief Financial Officer (Principal Financial Officer)"}